A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.

about

A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.

Item

http://www.wikidata.org/entity/Q53549934

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A 3-year interval is too short ...... population-based cohort study.

@en

A 3-year interval is too short ...... population-based cohort study.

@nl

type

Item

label

A 3-year interval is too short ...... population-based cohort study.

@en

A 3-year interval is too short ...... population-based cohort study.

@nl

prefLabel

A 3-year interval is too short ...... population-based cohort study.

@en

A 3-year interval is too short ...... population-based cohort study.

@nl

P1476

A 3-year interval is too short ...... population-based cohort study.

@en

P2093

A Bertazzo

http://www.w3.org/2001/XMLSchema#string

A Del Mistro

http://www.w3.org/2001/XMLSchema#string

C Fedato

http://www.w3.org/2001/XMLSchema#string

F Ortu

http://www.w3.org/2001/XMLSchema#string

M Campagnolo

http://www.w3.org/2001/XMLSchema#string

M G Penon

http://www.w3.org/2001/XMLSchema#string

M Rizzi

http://www.w3.org/2001/XMLSchema#string

M Rugge

http://www.w3.org/2001/XMLSchema#string

S Callegaro

http://www.w3.org/2001/XMLSchema#string

and the Veneto HPV-screening Working Group

http://www.w3.org/2001/XMLSchema#string

P2860

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

P304

1585-1593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1471-0528.14575

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Zorzi

Helena Frayle

P577

2017-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28120382

http://www.w3.org/2001/XMLSchema#string